Cargando…

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey

Detalles Bibliográficos
Autores principales:	Alves, Venancio Avancini Ferreira, D’Albuquerque, Luiz Augusto Carneiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975782/ https://www.ncbi.nlm.nih.gov/pubmed/27626470 http://dx.doi.org/10.6061/clinics/2016(08)02

Ejemplares similares

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
por: Cotrim, Helma P., et al.
Publicado: (2016)

Steatosis and steatohepatitis found in adults after death due to non-burn trauma
por: Reis-Júnior, Paulo, et al.
Publicado: (2019)

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
por: Alencar, Regiane Saraiva de Souza Melo, et al.
Publicado: (2022)

Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Ramachandran, Prasanna, et al.
Publicado: (2022)

Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
por: Koo, Seo-Young, et al.
Publicado: (2020)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
por: Gupta, Tarana
Publicado: (2022)

The regulatory state of nonalcoholic steatohepatitis and metabolism
por: Omokaro, Stephanie O., et al.
Publicado: (2020)

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
por: Kutlu, Ozlem, et al.
Publicado: (2018)

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
por: Peiseler, Moritz, et al.
Publicado: (2021)

Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Hirsova, Petra, et al.
Publicado: (2021)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Nature or Nurture? The Answer Is “Both” in Nonalcoholic Steatohepatitis
por: Carr, Rotonya M.
Publicado: (2020)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
por: Zhang, Yao, et al.
Publicado: (2022)

Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
por: Cernea, Simona, et al.
Publicado: (2023)

Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma
por: Wu, Jian
Publicado: (2016)

Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience
por: Shrager, Brian, et al.
Publicado: (2012)

Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Sircana, Antonio, et al.
Publicado: (2019)

Histological Grading of Hepatocellular Carcinoma—A Systematic Review of Literature
por: Martins-Filho, Sebastiao N., et al.
Publicado: (2017)

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma
por: Tucker, Robin D., et al.
Publicado: (2019)

First Latin uterine transplantation: we can do it!
por: Soares, José Maria, et al.
Publicado: (2016)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
por: Ali, Mahmoud A, et al.
Publicado: (2017)

Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis
por: Suwa, Kanehiko, et al.
Publicado: (2020)

Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis
por: Noto, Haruka, et al.
Publicado: (2014)

Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis
por: Garcia Whitlock, Anna E., et al.
Publicado: (2020)

Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
por: Jeong, Jain, et al.
Publicado: (2020)

The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate
por: Jiang, Xiaojun, et al.
Publicado: (2021)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013)

Surgical Management of Spontaneous Ruptured Hepatocellular Adenoma
por: Ribeiro Junior, Marcelo Augusto Fontenelle, et al.
Publicado: (2009)

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
por: Chung, Goh Eun, et al.
Publicado: (2013)

Lamin Deficiency in the Liver Sets the Stage for Nonalcoholic Steatohepatitis Development in Males
por: Hendrikx, Tim, et al.
Publicado: (2017)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2023)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2023)

A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?
por: Toman, Daniel, et al.
Publicado: (2022)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis
por: Bissoondial, Tyler L., et al.
Publicado: (2020)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
por: Kalogirou, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mnolhgq5jrp6ou20djsn291g3n